Fas-associated death receptor signaling evoked by human amylin in islet β-cellsd

Diabetes

Volumn 57, Issue 2, 2008, Pages 348-356

  Zhang, Shaoping ^a,b   Liu, Hong ^a   Yu, Hua ^a   Cooper, Garth J S ^a,b,c  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLIN; DEATH RECEPTOR; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FAS LIGAND; AMYLOID;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BETA SHEET; CELL ISOLATION; CELL LINE; DIABETOGENESIS; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; INSULINOMA; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN SYNTHESIS INHIBITION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; DRUG EFFECT; GENETICS; MOUSE STRAIN; PANCREAS ISLET; PHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

AMYLOID; ANIMALS; CELL LINE, TUMOR; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; HUMANS; INSULINOMA; ISLETS OF LANGERHANS; MALE; MICE; MICE, INBRED STRAINS; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 40749084493     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db07-0849     Document Type: Article

References (57)

1. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC: β-cell deficit and increased β-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102-110, 2003
2. Kahn SE: The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type-2 diabetes. Diabetologia 46:3-19, 2003
3. Cooper GJS, Willis AC, Clark A, Turner RC, Sim RB, Reid KBM: Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci USA 84:8628-8632, 1987
4. Westermark P, Wernstedt C, Wilander E, Hayden DW, O'Brien TD, Johnson KH: Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. Proc Natl Acad Sci USA84:3881-3885, 1987
5. Cooper GJS: Amylin compared with calcitonin gene-related peptide: structure, biology, and relevance to metabolic disease. Endocr Rev 15:163-201, 1994
6. Lukinius A, Wilander E, Westermark GT, Engström U, Westermark P: Co-localization of islet amyloid polypeptide and insulin in the B cell secretory granules of the human pancreatic islets. Diabetologia 32:240-244, 1989
7. Cooper GJS, Day AJ, Willis AC, Roberts AN, Reid KBM, Leighton B: Amylin and the amylin gene: structure, function and relationship to islet amyloid and to diabetes mellitus. Biochim Biophys Acta 1014:247-258, 1989
8. Goldsbury CS, Cooper GJS, Goldie KN, Muller SA, Saafi EL, Gruijters WTM, Misur MP, Engel A, Aebi U, Kistler J: Polymorphic fibrillar assembly of human amylin. J Struct Biol 119:17 27, 1997
9. Kapurniotu A: Amyloidogenicity and cytotoxicity of islet amyloid polypeptide. Biopolymers 60:438-459, 2001
10. Westermark P, Engström U, Johnson KH, Westermark GT, Betsholtz C: Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation. Proc Natl Acad SciUSA 87:5036-5040, 1990
11. Janson J, Soeller WC, Roche PC, Nelson RT, Torchia AJ, Kreutter DK, Butler PC: Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide. Proc Natl Acad Sci USA93:7283-7288, 1996
12. Lorenzo A, Razzaboni B, Weir GC, Yankner BA: Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. Nature 368: 756-760, 1994
13. Kahn SE, Andrikopoulos S, Verchere CB: Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes. Diabetes 48:241-253, 1999
14. Butler AE, Janson J, Soeller WC, Butler PC: Increased β-cell apoptosis prevents adaptive increase in β-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid. Diabetes 52:2304-2314, 2003
15. Ritzel RA, Meier JJ, Lin CY, Veldhuis JD, Butler PC: Human islet amyloid polypeptide oligomers disrupt cell coupling, induce apoptosis, and impair insulin secretion in isolated human islets. Diabetes 56:65-71, 2007
16. Zhang SP, Liu JX, Dragunow M, Cooper GJS: Fibrillogenic amylin evokes islet beta-cell apoptosis through linked activation of a caspase cascade and JNK1. J Biol Chem 278:52810-52819, 2003
17. Zhang SP, Liu JX, Saafi EL, Cooper GJS: Induction of apoptosis by human amylin in RINm5F islet beta-cells is associated with enhanced expression of p53 and p21(WAF1/CIP1). FEBS Lett 455:315-320, 1999
18. Couce M, Kane LA, O'Brien TD, Charlesworth J, Soeller W, McNeish J, Kreutter D, Roche P, Butler PC: Treatment with growth hormone and dexamethasone in mice transgenic for human islet amyloid polypeptide causes islet amyloidosis and β-cell dysfunction. Diabetes 45:1094-1101, 1996
19. Verchere CB, D'Alessio DA, Palmiter RD, Weir GC, Bonner-Weir S, Baskin DG, Kahn SE: Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide. Proc Natl Acad Sci USA93:3492-3496, 1996
20. Meier JJ, Kayed R, Lin CY, Gurlo T, Haataja L, Jayasinghe S, Langen R, Glabe CG, Butler PC: Inhibition of human IAPP fibril formation does not prevent beta-cell death: evidence for distinct actions of oligomers and fibrils of human IAPP. Am J Physiol Endocrinol Metab 291:E1317-E1324, 2006
21. Zhang SP, Liu H, Liu JX, Tse CA, Dragunow M, Cooper GJS: Activation of activating transcription factor 2 by p38 MAP kinase during apoptosis induced by human amylin in cultured pancreatic beta-cells. FEBS J 273:3779-3791, 2006
22. Janson J, Ashley RH, Harrison D, McIntyre S, Butler PC: The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate- sized toxic amyloid particles. Diabetes 48:491-498, 1999
23. Janciauskiene S, Ahren B: Fibrillar islet amyloid polypeptide differentially affects oxidative mechanisms and lipoprotein uptake in correlation with cytotoxicity in two insulin-producing cell lines. Biochem Biophys Res Commun 267:619-625, 2000
24. Lin CY, Gurlo T, Kayed R, Butler AE, Haataja L, Glabe CG, Butler PC: Toxic human islet amyloid polypeptide (h-IAPP) oligomers are intracellular, and vaccination to induce anti-toxic oligomer antibodies does not prevent h-IAPP-induced β-cell apoptosis in h-IAPP transgenic mice. Diabetes 56:1324-1332, 2007
25. Oyadomari S, Koizumi A, Takeda K, Gotoh T, Akira S, Araki E, Mori M: Targeted disruption of the chop gene delays endoplasmic reticulum stress-mediated diabetes. J Clin Invest 109:525-532, 2002
26. Zhang SP, Liu JX, MacGibbon G, Dragunow M, Cooper GJS: Increased expression and activation of c-Jun contributes to human amylin-induced apoptosis in pancreatic islet beta-cells. J Mol Biol 324:271-285, 2002
27. Darville MI, Liu D, Chen MC, Eizirik DL: Molecular regulation of Fas expression in β-cells. Diabetes 50 (Suppl. 1):S83, 2001
28. Chervonsky AV, Wang Y, Wong FS, Visintin I, Flavell RA, Janeway CAJ, Matis LA: The role of Fas in autoimmune diabetes. Cell 89:17-24, 1997
29. Stassi G, De Maria R, Trucco G, Rudert W, Testi R, Galluzzo A, Giordano C, Trucco M: Nitric oxide primes pancreatic beta cells for Fas-mediated destruction in insulin-dependent diabetes mellitus. J Exp Med 186:1193-1200, 1997
30. Itoh N, Imagawa A, Hanafusa T, Waguri M, Yamamoto K, Iwahashi H, Moriwaki M, Nakajima H, Miyagawa J, Namba M, Makino S, Nagata S, Kono N, Matsubara Y: Requirement of Fas for the development of autoimmune diabetes in nonobese diabetic mice. J Exp Med 186:613-618, 1997
31. Chinnaiyan A, O'Rourke K, Tewari M, Dixit V: FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81:505-512, 1995
32. Yamada K, Takane-Gyotoku N, Yuan X, Ichikawa F, Inada C, Nonaka K: Mouse islet cell lysis mediated by interleukin-1-induced Fas. Diabetologia 39:1306-1312, 1996
33. Maedler K, Donath MY: Beta-cells in type 2 diabetes: a loss of function and mass. Hormone Res 62 (Suppl. 3):67-73, 2004
34. Maedler K, Spinas GA, Lehmann R, Sergeev P, Weber M, Fontana A, Kaiser N, Donath MY: Glucose induces β-cell apoptosis via upregulation of the Fas receptor in human islets. Diabetes 50:1683-1690, 2001
35. Konarkowska B, Aitken JF, Kistler J, Zhang S, Cooper GJS: The aggregation potential of human amylin determines its cytotoxicity towards islet beta-cells. FEBS J 273:3614-3624, 2006
36. Lacy PE, Kostianovsky M: Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 16:35-39, 1967
37. Rumora L, Hadzija M, Barisic K, Maysinger D, Grubiic TZ: Amylin-induced cytotoxicity is associated with activation of caspase-3 and MAP kinases. Biol Chem 383:1751-1758, 2002
38. Peter M, Krammer P: Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis. Curr Opin Immunol 10:545-551, 1998
39. Ashkenazi A, Dixit V: Death receptor: signaling and modulation. Science 281:1305-1308, 1998
40. Chang HY, Nishitoh H, Yang X, Ichijo H, Baltimore D: Activation of apoptosis signal-regulating kinase 1 (ASK1) by the adapter protein Daxx. Science 281:1860-1863, 1998
41. Yang X, Khosravi-Far R, Chang HY, Baltimore D: Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell 89:1067-1076, 1997
42. Saafi EL, Konarkowska B, Zhang S, Kistler J, Cooper GJS: Ultrastructural evidence that apoptosis is the mechanism by which human amylin evokes death in RINm5F pancreatic islet β-cells. Cell Biol Intl 25:339-350, 2001
43. Goldstein J, Anderson R, Brown M: Coated pits, coated vesicles, and receptor-mediated endocytosis. Nature 279:679-685, 1979
44. Banner DW, D'Arcy A, Janes W, Gentz R, Schoenfeld HJ, Broger C, Loetscher H, Lesslauer W: Crystal structure of the soluble human 55kd TNF receptor-human TNF beta complex: implications for TNF receptor activation. Cell 73:431-445 1993
45. Nagata S: Fas ligand-induced apoptosis. Annu Rev Genet 33:29 -55, 1999
46. Konarkowska B, Aitken JF, Kistler J, Zhang S, Cooper GJS: Thiol reducing compounds prevent human amylin-evoked cytotoxicity. FEBS J272:4949-4959, 2005
47. Ivins KJ, Thornton PL, Rohn TT, Cotman CW: Neuronal apoptosis induced by beta-amyloid is mediated by caspase-8. Neurobiol Disease 6:440-449, 1999
48. Su JH, Anderson AJ, Cribbs DH, Tu C, Tong L, Kesslack P, Carl WC: Fas and Fas Ligand are associated with neuritic degeneration in the AD brain and participate in beta-amyloid-induced neuronal death. Neurobiol Disease 12:182-193, 2003
49. Hasegawa A, Cheng X, Kajino K, Berezov A, Murata K, Nakayama T, Yagita H, Murali R, Greene MI: Fas-disabling small exocyclic peptide mimetics limit apoptosis by an unexpected mechanism. Proc Natl Acad Sci USA 101:6599-6604, 2004
50. Aitken JF, Loomes KM, Konarkowska B, Cooper GJS: Suppression by polycyclic compounds of the conversion of human amylin into insoluble amyloid. Biochem J 374:779-784, 2003
51. Li J, Rajamani S, Uversky V, Fink A: Rifampicin inhibits alpha-synuclein fibrillation and disaggregates fibrils. Chem Biol 11:1513-1521, 2004
52. Harroun TA, Bradshaw JP, Ashley RH: Inhibitors can arrest the membrane activity of human islet amyloid polypeptide independently of amyloid formation. FEBS Lett 507:200-204, 2001
53. Kapurniotu A, Schmauder A, Tenidis K: Structure-based design and study of non-amyloidogenic, double N-methylated IAPP amyloid core sequences as inhibitors of IAPP amyloid formation and cytotoxicity. J Mol Biol 315:339-350, 2002
54. Yan LM, Tatarek-Nossol M, Velkova A, Kazantzis A, Kapurniotu A: Design of a mimic of nonamyloidogenic and bioactive human islet amyloid polypeptide (IAPP) as nanomolar affinity inhibitor of IAPP cytotoxic fibrillogenesis. Proc Natl Acad Sci USA 103:2046-2051, 2006
55. Tatarek-Nossol M, Yan LM, Schmauder A, Tenidis K, Westermark G, Kapurniotu A: Inhibition of hIAPP amyloid-fibril formation and apoptotic cell death by a designed hIAPP amyloid-core-containing hexapeptide. Chem Biol 12:797-809, 2005
56. Scrocchi LA, Chen Y, Waschuk S, Wang F, Cheung S, Darabie AA, McLaurin J, Fraser PE: Design of peptide-based inhibitors of human islet amyloid polypeptide fibrillogenesis. J Mol Biol 318:697-706, 2002
57. Goldsbury C, Goldie K, Pellaud J, Seelig J, Frey P, Muller SA, Kistler J, Cooper GJS, Aebi U: Amyloid fibril formation from full-length and fragments of amylin. J Struct Biol 130:352-362, 2000